Langerhans cell histiocytosis is a rare inflammatory neoplasm of myeloid origin characterized by the presence of classic CD1A+CD207+ histiocytes notorious for aberrant function secondary to activating somatic mutations in the MAPK (RAS–RAF–MEK–ERK) pathway. Here, CD207 is linked to Langerhans cell histiocytosis.